These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22734706)

  • 21. Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues.
    Ji L; Chen FE; Feng XQ; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1248-53. PubMed ID: 16946529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graph theory concepts in the rationales of anti HIV-1 compounds.
    Debnath U; Katti SB; Prabhakar YS
    Curr Comput Aided Drug Des; 2013 Dec; 9(4):472-81. PubMed ID: 24138418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in anti-HIV chemotherapy.
    De Clercq E
    Curr Med Chem; 2001 Nov; 8(13):1543-72. PubMed ID: 11562282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
    Kireev DB; Chrétien JR; Grierson DS; Monneret C
    J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.
    Santos LH; Ferreira RS; Caffarena ER
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):847-64. PubMed ID: 26560977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
    Chen KX; Xie HY; Li ZG; Gao JR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four-dimensional structure-activity relationship model to predict HIV-1 integrase strand transfer inhibition using LQTA-QSAR methodology.
    de Melo EB; Ferreira MM
    J Chem Inf Model; 2012 Jul; 52(7):1722-32. PubMed ID: 22657398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family.
    Chen W; Zhan P; Wu J; Li Z; Liu X
    Curr Pharm Des; 2012; 18(27):4165-86. PubMed ID: 22621244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANN QSAR workflow for predicting the inhibition of HIV-1 reverse transcriptase by pyridinone non-nucleoside derivatives.
    Barzegar A; Zamani-Gharehchamani E; Kadkhodaie-Ilkhchi A
    Future Med Chem; 2017 Jul; 9(11):1175-1191. PubMed ID: 28722475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives.
    Darnag R; Mostapha Mazouz EL; Schmitzer A; Villemin D; Jarid A; Cherqaoui D
    Eur J Med Chem; 2010 Apr; 45(4):1590-7. PubMed ID: 20110136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
    Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
    Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linear and nonlinear quantitative structure-activity relationship modeling of the HIV-1 reverse transcriptase inhibiting activities of thiocarbamates.
    Goodarzi M; Freitas MP; Vander Heyden Y
    Anal Chim Acta; 2011 Oct; 705(1-2):166-73. PubMed ID: 21962359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMILES in QSPR/QSAR Modeling: results and perspectives.
    Toropov AA; Benfenati E
    Curr Drug Discov Technol; 2007 Aug; 4(2):77-116. PubMed ID: 17691912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
    Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
    Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR and Pharmacophore Mapping Studies on Benzothiazinimines to Relate their Structural Features with anti-HIV Activity.
    Geethaavacini G; Poh GP; Yan LY; Deepashini R; Shalini S; Harish R; Sureshkumar K; Ravichandran V
    Med Chem; 2018; 14(7):733-740. PubMed ID: 29807521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?
    Camarasa MJ; Velázquez S; San-Félix A; Pérez-Pérez MJ; Gago F
    Antiviral Res; 2006 Sep; 71(2-3):260-7. PubMed ID: 16872687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.